Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency
/in International Publications, NSCLC /von 2007-06-27 / Int. J. Clin. Oncol. 2007 Jun;12(3):192-8Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours
/in Cervical Cancer, Dendritic Cells, International Publications /von 2007-06-08 / Vaccine 2007 Aug;25(32):6037-46Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells
/in International Publications, Malignant Melanoma /von 2007-06-01 / Melanoma Res. 2007 Jun;17(3):169-76[Active immunotherapy of prostate cancer with a focus on dendritic cells]
/in International Publications, Prostate Cancer /von 2007-06-01 / Actas Urol Esp 2007 Jun;31(6):668-79Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
/in Dendritic Cells, Hyperthermia, International Publications, Malignant Melanoma /von 2007-06-01 / Int. J. Cancer 2007 Jun;120(11):2418-25Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil
/in Breast Cancer, Hyperthermia, International Publications /von 2007-06-01 / J. Exp. Clin. Cancer Res. 2007 Jun;26(2):201-7Dendritic cells and T lymphocyte interactions in patients with lymphoid malignancies
/in Chronic Leukemia, International Publications, Malignant Lymphoma /von 2007-05-30 / Physiol Res 2008;57(2):289-98Immunological response in the mouse melanoma model after local hyperthermia
/in Hyperthermia, International Publications, Malignant Melanoma /von 2007-05-30 / Physiol Res 2008;57(3):459-65Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
/in Hepatocellular Carcinoma, International Publications /von 2007-05-24 / Cancer Immunol. Immunother. 2007 Dec;56(12):1931-43IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de